Welcome to LookChem.com Sign In|Join Free
The company logo of Chemvon Biotechnology Co. Ltd.

Chemvon Biotechnology Co. Ltd.

Assessed Supplier Enterprise Certification

Assessed
Supplier
17th
years

Chemvon Biotechnology Co. Ltd.

Business Type:Lab/Research institutions

Audited Supplier

Main Products:
Atocalcitol ,Inecalcitol,Alvimopan ,Fosaprepitant, Bimatoprost,Lubiprostone,Tafluprost
Year Established:
2008
Home>>Products>>Lubiprostone

Product Certification&
Enterprise Certification

More Detail

Chemvon Biotechnology Co. Ltd.

Country: China (Mainland)

Business Type:Lab/Research institutions

Mr.peter

Tel: 86-21-58550039;86-21-31268550-8004

Mobile:

Tel: 86-21-58550039;86-21-31268550-8004

Fax: 86-21-50790419

URL: http://www.chemvon.com

Province/state: shanghai

City: shanghai

Street: Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China

MaxCard:


Contact Suppliers

Lubiprostone

CAS NO.136790-76-6

  • Min.Order: 1 Gram
  • Payment Terms:
Contact Supplier

Product Details

Keywords

  • Lubiprostone manufacturer
  • Lubiprostone APIs

Quick Details

  • ProName: Lubiprostone
  • CasNo: 136790-76-6
  • Molecular Formula: C20H32F2O5
  • Appearance: white
  • Port: any port in China
  • ProductionCapacity: Metric Ton/Day
  • Purity: 99
  • Storage: Store at -20° C
  • Transportation: as requested
  • LimitNum: 1 Gram
  • Grade: Pharma Grade

Superiority

Chemvon Biotechnology is one of the leading high-technology manufacturer in the field of pharmaceutical and fine chemical industry.

From origins as a research group in technology service, chemvon has progressed into an integrated company with a kilo lab and a pilot plant offering a range of APIs, NCEs and some organic intermediates.

Lubiprostone is our regular products. 

Details

APIs 

English Name:   Lubiprostone   

CAS Number:   136790-76-6 

 Molecular Formula:   C20H32F2O5 

 Molecular Weight:   390.2218

Lubiprostone is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.